Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential

Overview of attention for article published in Journal of Medicinal Chemistry, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 4 X users
patent: 47 patents

wikipedia: 3 Wikipedia pages

Readers on

mendeley: 292 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 47 patents that reference this research output.

AZACYCLOALKANE COMPOUND AND PHARMACEUTICAL COMPOSITION, AND USE THEREOF

Application EP-4653439-A4

European Patent Office

29 Apr 2026

Dihydrofuropyridine derivatives as rho-kinase inhibitors

Grant US-12534474-B2

United States of America

27 Jan 2026

METHODS OF TREATING CORTICAL DEMENTIA ASSOCIATED WANDERING

Application EP-4616909-A2

European Patent Office

17 Sep 2025

Azaindole rock inhibitors

Grant US-12415805-B2

United States of America

16 Sep 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 43 additional patents.